Business Context and Reporting Period
This Form 6-K filing by The9 Limited (The9) covers the month of April 2021. The report details the entry into a Material Definitive Agreement, specifically an Underwriting Agreement dated March 31, 2021, with Maxim Group LLC and other underwriters for an underwritten public offering of American Depositary Shares (ADSs) and ADS warrants.
Key Financial Metrics and Transaction Details
- Offering Structure: The Company issued 3,765,100 Firm ADSs (representing 112,953,000 Class A ordinary shares) and Firm Warrants to purchase 2,823,825 ADSs.
- Offering Price: $33.20 per ADS and accompanying 0.75 ADS warrant.
- Warrant Terms: Exercise price of $36.00 per ADS; exercisable upon issuance; expiration three years from issuance.
- Over-Allotment: The underwriters exercised their option to purchase 564,760 Option ADSs and 423,570 Option Warrants.
- Gross Proceeds: Approximately $125 million from the initial offering and an additional approximately $19 million from the over-allotment exercise (totaling approximately $144 million gross).
- Use of Proceeds: Intended for working capital and other general corporate purposes.
Note: This filing does not provide standard operating financial metrics such as revenue, net profit, operating cash flow, or debt levels for the reporting period.
Material Changes
The primary material change reported is the successful closing of the equity offering on April 5, 2021, resulting in a significant increase in the Company's cash position through gross proceeds of approximately $144 million. Additionally, the Company granted Maxim Group LLC a 12-month right of first refusal to act as co-underwriter and book runner for future offerings with a minimum portion of at least $10.0 million.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the anticipated net proceeds and their intended use. Management cautions that these statements involve risks and uncertainties, including the ability to satisfy closing conditions. The Company explicitly states it does not intend to revise or update these forward-looking statements to reflect future events except as required by law. No specific operational guidance or revenue outlook is provided in this document.
Key Facts for Investor Verification
- Verify the final net proceeds after deducting underwriting discounts, commissions, and offering expenses.
- Confirm the exact number of outstanding shares and warrants post-offering to assess dilution impact.
- Review the specific terms of the right of first refusal granted to Maxim Group LLC for future capital raises.
- Monitor the Company's actual deployment of the approximately $144 million in gross proceeds against the stated purpose of working capital.